More on Enanta Pharma fiscal Q3 results

Enanta Pharmaceuticals (NASDAQ:ENTA) fiscal Q3 results: Revenues: $42.1M (+999%); Operating Expenses: $7.2M (+22.8%); Operating Income: $34.9M (+935.2%); Net Income: ($50.1M) (+999%); EPS: ($2.61) (+999%); Quick Assets: $95.9M (-5.5%).

No financial guidance given.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs